Drug Delivery and Glaucoma: Dextenza for Xen Patients

Show Description +

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Drug Delivery and Glaucoma: Dextenza for Xen Patients

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Please log in to leave a comment.

More in Glaucoma

Exploring Surgical Options for a Young Glaucoma Patient

Rachel G. Simpson, MD; Roya Garakani, DO; and Craig J. Chaya, MD

Introducing the Elara 900

Iqbal Ike K. Ahmed, MD, FRCSC

The Evolving Landscape of Viscodilation

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Christine M. Funke, MD